Enfortumab vedotin as a promising treatment option for bladder cancer: phase 2 results Presented ByDr Arjun Vasant Balar, NYU Langone Medical Oncology, USA ConferenceASCO GU 2021 24 March, 2021 15:02
Enfortumab vedotin highly active in previously treated advanced urothelial carcinoma Presented ByDr Daniel P. Petrylak, Yale School of Medicine, USA TrialEV-201, EV-301 ConferenceASCO 2019 15 July, 2019 13:42